Document Detail

CT screening for lung cancer.
MedLine Citation:
PMID:  23137673     Owner:  NLM     Status:  Publisher    
Lung cancer is a common and serious disease, only early stage are curable. It is a logical candidate for a screening policy, especially as current and former smokers are easy to identify. The inefficiency of the chest radiograph is now proven, while the low-dose CT has shown promising data following a recent randomized study in North America. Yet, this is not specific and find a great number of benign anomalies. These limitations must be well known to physicians, radiologists and chest physicians if they use the individual screening.
Valérie Gounant; Jalal Assouad; Armelle Lavolé; Marie Wislez; Jacques Cadranel; Bernard Milleron
Related Documents :
25047403 - Effect of acculturation and access to care on colorectal cancer screening in low-income...
24643703 - Compounds from chinese herbal medicines as reversal agents for p-glycoprotein-mediated ...
23054213 - The parp inhibitor abt-888 synergizes irinotecan treatment of colon cancer cell lines.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-9
Journal Detail:
Title:  Bulletin du cancer     Volume:  -     ISSN:  1769-6917     ISO Abbreviation:  Bull Cancer     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0072416     Medline TA:  Bull Cancer     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Hôpital Tenon, service de pneumologie, 4, rue de la Chine 75020 Paris, France, Hôpital Tenon, service de chirurgie thoracique, 4, rue de la Chine 75020 Paris, France.
Vernacular Title:
Le dépistage scanographique du cancer bronchopulmonaire.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Stem cells in dentistry - Part II: Clinical applications.
Next Document:  Mouse liver-specific CD8(+) T-cells encounter their cognate antigen and acquire capacity to destroy ...